CINTAS CORP (CIT.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:CIT • US1729081059

165 EUR
-0.15 (-0.09%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

7

Taking everything into account, CIT scores 7 out of 10 in our fundamental rating. CIT was compared to 42 industry peers in the Commercial Services & Supplies industry. CIT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CIT is valued expensive at the moment. This makes CIT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • CIT had positive earnings in the past year.
  • In the past year CIT had a positive cash flow from operations.
  • Each year in the past 5 years CIT has been profitable.
  • In the past 5 years CIT always reported a positive cash flow from operatings.
CIT.DE Yearly Net Income VS EBIT VS OCF VS FCFCIT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • CIT's Return On Assets of 18.67% is amongst the best of the industry. CIT outperforms 100.00% of its industry peers.
  • CIT has a better Return On Equity (42.46%) than 97.62% of its industry peers.
  • CIT has a better Return On Invested Capital (24.58%) than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CIT is significantly above the industry average of 8.66%.
  • The 3 year average ROIC (21.68%) for CIT is below the current ROIC(24.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROIC 24.58%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
CIT.DE Yearly ROA, ROE, ROICCIT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • CIT has a Profit Margin of 17.52%. This is amongst the best in the industry. CIT outperforms 97.62% of its industry peers.
  • In the last couple of years the Profit Margin of CIT has grown nicely.
  • Looking at the Operating Margin, with a value of 22.98%, CIT belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CIT has grown nicely.
  • CIT has a Gross Margin (50.25%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of CIT has grown nicely.
Industry RankSector Rank
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
CIT.DE Yearly Profit, Operating, Gross MarginsCIT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CIT is creating value.
  • Compared to 1 year ago, CIT has less shares outstanding
  • Compared to 5 years ago, CIT has less shares outstanding
  • The debt/assets ratio for CIT has been reduced compared to a year ago.
CIT.DE Yearly Shares OutstandingCIT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CIT.DE Yearly Total Debt VS Total AssetsCIT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 12.04 indicates that CIT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 12.04, CIT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • CIT has a debt to FCF ratio of 1.67. This is a very positive value and a sign of high solvency as it would only need 1.67 years to pay back of all of its debts.
  • The Debt to FCF ratio of CIT (1.67) is better than 88.10% of its industry peers.
  • A Debt/Equity ratio of 0.54 indicates that CIT is somewhat dependend on debt financing.
  • CIT's Debt to Equity ratio of 0.54 is fine compared to the rest of the industry. CIT outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Altman-Z 12.04
ROIC/WACC2.84
WACC8.65%
CIT.DE Yearly LT Debt VS Equity VS FCFCIT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.3 Liquidity

  • CIT has a Current Ratio of 1.71. This is a normal value and indicates that CIT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CIT (1.71) is better than 76.19% of its industry peers.
  • A Quick Ratio of 1.49 indicates that CIT should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.49, CIT is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.49
CIT.DE Yearly Current Assets VS Current LiabilitesCIT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

6

3. Growth

3.1 Past

  • CIT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.63%, which is quite good.
  • CIT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.84% yearly.
  • The Revenue has grown by 8.60% in the past year. This is quite good.
  • Measured over the past years, CIT shows a small growth in Revenue. The Revenue has been growing by 7.85% on average per year.
EPS 1Y (TTM)11.63%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%11.01%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%9.3%

3.2 Future

  • CIT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.23% yearly.
  • CIT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.20% yearly.
EPS Next Y12.8%
EPS Next 2Y11.82%
EPS Next 3Y11.34%
EPS Next 5Y11.23%
Revenue Next Year8.74%
Revenue Next 2Y8.07%
Revenue Next 3Y7.75%
Revenue Next 5Y8.2%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CIT.DE Yearly Revenue VS EstimatesCIT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
CIT.DE Yearly EPS VS EstimatesCIT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 42.09 indicates a quite expensive valuation of CIT.
  • The rest of the industry has a similar Price/Earnings ratio as CIT.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, CIT is valued quite expensively.
  • CIT is valuated quite expensively with a Price/Forward Earnings ratio of 35.30.
  • CIT's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. CIT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 42.09
Fwd PE 35.3
CIT.DE Price Earnings VS Forward Price EarningsCIT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 64.29% of the companies in the same industry are cheaper than CIT, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CIT is valued a bit more expensive than 61.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 43.93
EV/EBITDA 27.18
CIT.DE Per share dataCIT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CIT does not grow enough to justify the current Price/Earnings ratio.
  • CIT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.29
PEG (5Y)2.5
EPS Next 2Y11.82%
EPS Next 3Y11.34%

3

5. Dividend

5.1 Amount

  • CIT has a yearly dividend return of 0.95%, which is pretty low.
  • CIT's Dividend Yield is comparable with the industry average which is at 2.56.
  • Compared to an average S&P500 Dividend Yield of 1.83, CIT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

  • On average, the dividend of CIT grows each year by 18.49%, which is quite nice.
Dividend Growth(5Y)18.49%
Div Incr YearsN/A
Div Non Decr YearsN/A
CIT.DE Yearly Dividends per shareCIT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2025 2026 1 2 3

5.3 Sustainability

  • 34.69% of the earnings are spent on dividend by CIT. This is a low number and sustainable payout ratio.
  • CIT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.69%
EPS Next 2Y11.82%
EPS Next 3Y11.34%
CIT.DE Yearly Income VS Free CF VS DividendCIT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CIT.DE Dividend Payout.CIT.DE Dividend Payout, showing the Payout Ratio.CIT.DE Dividend Payout.PayoutRetained Earnings

CINTAS CORP

FRA:CIT (2/6/2026, 7:00:00 PM)

165

-0.15 (-0.09%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)12-18
Earnings (Next)03-24
Inst Owners66.98%
Inst Owner ChangeN/A
Ins Owners1.65%
Ins Owner ChangeN/A
Market Cap66.31B
Revenue(TTM)10.79B
Net Income(TTM)1.89B
Analysts70.37
Price Target190.68 (15.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend1.27
Dividend Growth(5Y)18.49%
DP34.69%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.88%
Min EPS beat(2)-0.91%
Max EPS beat(2)-0.85%
EPS beat(4)1
Avg EPS beat(4)0.77%
Min EPS beat(4)-0.91%
Max EPS beat(4)4.93%
EPS beat(8)5
Avg EPS beat(8)3.74%
EPS beat(12)8
Avg EPS beat(12)2.8%
EPS beat(16)12
Avg EPS beat(16)3.25%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)-0.74%
Revenue beat(4)0
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-1.5%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-1.32%
Revenue beat(12)0
Avg Revenue beat(12)-1.13%
Revenue beat(16)4
Avg Revenue beat(16)-0.57%
PT rev (1m)0.95%
PT rev (3m)-59.8%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.08%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 42.09
Fwd PE 35.3
P/S 7.25
P/FCF 43.93
P/OCF 35.5
P/B 17.56
P/tB 116.05
EV/EBITDA 27.18
EPS(TTM)3.92
EY2.38%
EPS(NY)4.67
Fwd EY2.83%
FCF(TTM)3.76
FCFY2.28%
OCF(TTM)4.65
OCFY2.82%
SpS22.77
BVpS9.4
TBVpS1.42
PEG (NY)3.29
PEG (5Y)2.5
Graham Number28.79
Profitability
Industry RankSector Rank
ROA 18.67%
ROE 42.46%
ROCE 30.79%
ROIC 24.58%
ROICexc 25.21%
ROICexgc 48.61%
OM 22.98%
PM (TTM) 17.52%
GM 50.25%
FCFM 16.5%
ROA(3y)17.06%
ROA(5y)15.93%
ROE(3y)36.52%
ROE(5y)35.33%
ROIC(3y)21.68%
ROIC(5y)20.31%
ROICexc(3y)22.42%
ROICexc(5y)21.1%
ROICexgc(3y)45.31%
ROICexgc(5y)44.66%
ROCE(3y)27.16%
ROCE(5y)25.44%
ROICexgc growth 3Y4.19%
ROICexgc growth 5Y9.87%
ROICexc growth 3Y7.31%
ROICexc growth 5Y10.45%
OM growth 3Y3.91%
OM growth 5Y6.07%
PM growth 3Y3.71%
PM growth 5Y7.35%
GM growth 3Y2.66%
GM growth 5Y1.86%
F-Score8
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 1.67
Debt/EBITDA 0.81
Cap/Depr 84.15%
Cap/Sales 3.92%
Interest Coverage 250
Cash Conversion 73.86%
Profit Quality 94.13%
Current Ratio 1.71
Quick Ratio 1.49
Altman-Z 12.04
F-Score8
WACC8.65%
ROIC/WACC2.84
Cap/Depr(3y)83.77%
Cap/Depr(5y)69.7%
Cap/Sales(3y)3.99%
Cap/Sales(5y)3.41%
Profit Quality(3y)98.91%
Profit Quality(5y)102.51%
High Growth Momentum
Growth
EPS 1Y (TTM)11.63%
EPS 3Y15.77%
EPS 5Y16.84%
EPS Q2Q%11.01%
EPS Next Y12.8%
EPS Next 2Y11.82%
EPS Next 3Y11.34%
EPS Next 5Y11.23%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y9.6%
Revenue growth 5Y7.85%
Sales Q2Q%9.3%
Revenue Next Year8.74%
Revenue Next 2Y8.07%
Revenue Next 3Y7.75%
Revenue Next 5Y8.2%
EBIT growth 1Y11.71%
EBIT growth 3Y13.89%
EBIT growth 5Y14.4%
EBIT Next Year31.7%
EBIT Next 3Y15.86%
EBIT Next 5Y13.68%
FCF growth 1Y35.78%
FCF growth 3Y10.65%
FCF growth 5Y10.61%
OCF growth 1Y29.87%
OCF growth 3Y12.1%
OCF growth 5Y10.89%

CINTAS CORP / CIT.DE FAQ

What is the ChartMill fundamental rating of CINTAS CORP (CIT.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CIT.DE.


Can you provide the valuation status for CINTAS CORP?

ChartMill assigns a valuation rating of 1 / 10 to CINTAS CORP (CIT.DE). This can be considered as Overvalued.


How profitable is CINTAS CORP (CIT.DE) stock?

CINTAS CORP (CIT.DE) has a profitability rating of 9 / 10.


What is the valuation of CINTAS CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CINTAS CORP (CIT.DE) is 42.09 and the Price/Book (PB) ratio is 17.56.


Can you provide the financial health for CIT stock?

The financial health rating of CINTAS CORP (CIT.DE) is 8 / 10.